Panacea Innovation Limited 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-17 4:15 pm Purchase | 2025-12-16 | 13D | CASI Pharmaceuticals, Inc. CASI | Panacea Innovation Limited | 4,651,527 22.500% | 989,956 (+27.04%) | Filing |
| 2025-09-26 6:45 pm Purchase | 2025-09-26 | 13D | CASI Pharmaceuticals, Inc. CASI | Panacea Innovation Limited | 3,661,571 19.900% | 3,661,571 (New Position) | Filing |